Acute respiratory distress syndrome (ARDS) is a severe, highly heterogeneous critical illness with staggering mortality that is influenced by environmental factors, such as mechanical ventilation, and genetic factors. Significant unmet needs in ARDS are addressing the paucity of validated predictive biomarkers for ARDS risk and susceptibility that hamper the conduct of successful clinical trials in ARDS and the complete absence of novel disease-modifying therapeutic strategies.
Recent Advances:
The current ARDS definition relies on clinical characteristics that fail to capture the diversity of disease pathology, severity, and mortality risk. We undertook a comprehensive survey of the available ARDS literature to identify genes and genetic variants (candidate gene and limited genome-wide association study approaches) implicated in susceptibility to developing ARDS in hopes of uncovering novel biomarkers for ARDS risk and mortality and potentially novel therapeutic targets in ARDS. We further attempted to address the well-known health disparities that exist in susceptibility to and mortality from ARDS.
Critical Issues:
Bioinformatic analyses identified 201 ARDS candidate genes with pathway analysis indicating a strong predominance in key evolutionarily conserved inflammatory pathways, including reactive oxygen species, innate immunity-related inflammation, and endothelial vascular signaling pathways.
Future Directions:
Future studies employing a system biology approach that combines clinical characteristics, genomics, transcriptomics, and proteomics may allow for a better definition of biologically relevant pathways and genotype–phenotype connections and result in improved strategies for the sub-phenotyping of diverse ARDS patients via molecular signatures. These efforts should facilitate the potential for successful clinical trials in ARDS and yield a better fundamental understanding of ARDS pathobiology.
Get full access to this article
View all access options for this article.
References
1.
This reference has been deleted.
2.
Acosta-HerreraM, Pino-YanesM, BlancoJ, BallesterosJC, AmbrósA, CorralesA, GandíaF, SubiráC, DomínguezD, BalujaA, AñónJM, AdaliaR, Pérez-MéndezL, FloresC, VillarJ, and for the GRECIA and GE N-SEP Networks. Common variants of NFE2L2 gene predisposes to acute respiratory distress syndrome in patients with severe sepsis. Crit Care, 19: 256, 2015.
3.
AdyshevDM, ElangovanVR, MoldobaevaN, MapesB, SunX, and GarciaJGN. Mechanical stress induces pre-B-cell colony-enhancing factor/NAMPT expression via epigenetic regulation by miR-374a and miR-568 in human lung endothelium. Am J Respir Cell Mol Biol, 50: 409–418, 2013.
4.
AhasicAM, ZhaoY, SuL, SheuC-C, ThompsonBT, and ChristianiDC. Adiponectin gene polymorphisms and acute respiratory distress syndrome susceptibility and mortality. PLoS One, 9: e89170, 2014.
5.
AkeyJM.Constructing genomic maps of positive selection in humans: where do we go from here?. Genome Res, 19: 711–722, 2009.
6.
AlbaicetaGM, Gutierrez-FernándezA, García-PrietoE, PuenteXS, ParraD, AstudilloA, CampestreC, CabreraS, Gonzalez-LopezA, FueyoA, TaboadaF, and López-OtinC. Absence or inhibition of matrix metalloproteinase-8 decreases ventilator-induced lung injury. Am J Respir Cell Mol Biol, 43: 555–563, 2010.
7.
AlbaicetaGM, Gutiérrez-FernándezA, ParraD, AstudilloA, García-PrietoE, TaboadaF, and FueyoA. Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol, 294: L535–L543, 2008.
8.
ARDSNet. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med, 342: 1301–1308, 2000.
9.
ArmstrongL, ThickettDR, ChristieSJ, KendallH, and MillarAB. Increased expression of functionally active membrane-associated tumor necrosis factor in acute respiratory distress syndrome. Am J Respir Cell Mol Biol, 22: 68–74, 2000.
10.
AshbaughD, Boyd BigelowD, PettyT, and LevineB. ACUTE respiratory distress in adults. Lancet, 290: 319–323, 1967.
11.
AzevedoZM, MooreDB, LimaFC, CardosoCC, BougleuxR, MatosGI, LuzRA, Xavier-ElsasP, SampaioEP, Gaspar-ElsasMI, and MoraesMO. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: importance in ARDS in septic pediatric critically ill patients. Hum Immunol, 73: 661–667, 2012.
12.
BajwaEK, YuC-L, GongMN, ThompsonBT, and ChristianiDC. Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome. Crit Care Med, 35: 1290–1295, 2007.
13.
BarkanD, KleinmanH, SimmonsJL, AsmussenH, KamarajuAK, HoenorhoffMJ, LiuZ-Y, CostesSV, ChoEH, LockettS, KhannaC, ChambersAF, and GreenJE. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res, 68: 6241–6250, 2008.
14.
BauerTT, MontónC, TorresA, CabelloH, FillelaX, MaldonadoA, NicolásJ-M, and ZavalaE. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax, 55: 46, 2000.
15.
BeckerKG, HosackDA, DennisGJr., LempickiRA, BrightTJ, CheadleC, and EngelJ.PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics, 4: 61, 2003.
16.
BellaniG, LaffeyJG, PhamT, FanE, BrochardL, EstebanA, GattinoniL, van HarenF, LarssonA, McAuleyDF, RanieriM, RubenfeldG, ThompsonBT, WriggeH, SlutskyAS, PesentiA; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA, 315: 788–800, 2016.
17.
BelopolskayaOB, SmelayaTV, MorozVV, GolubevAM, and SalnikovaLE. Clinical associations of host genetic variations in the genes of cytokines in critically ill patients. Clin Exp Immunol, 180: 531–541, 2015.
18.
BenvenisteEN, LiuY, McFarlandBC, and QinH. Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis. J Interferon Cytokine Res, 34: 577–588, 2014.
19.
BernardK, HeckerL, LuckhardtTR, ChengG, and ThannickalVJ. NADPH oxidases in lung health and disease. Antioxid Redox Signal, 20: 2838–2853, 2014.
20.
BernhagenJ, CalandraT, MitchellRA, MartinSB, TraceyKJ, VoelterW, ManogueKR, CeramiA, and BucalaR. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature, 365: 756, 1993.
21.
BhargavaM, BeckerTL, VikenKJ, JagtapPD, DeyS, SteinbachMS, WuB, KumarV, BittermanPB, IngbarDH, and WendtCH. Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors. PLoS One, 9: e109713, 2014.
22.
BhargavaM, VikenK, WangQ, JagtapP, BittermanP, IngbarD, and WendtC. Bronchoalveolar lavage fluid protein expression in acute respiratory distress syndrome provides insights into pathways activated in subjects with different outcomes. Sci Rep, 7: 7464, 2017.
23.
BimeC, PoongkunranC, BorgstromM, NattB, DesaiH, ParthasarathyS, and GarciaJGN. Racial differences in mortality from severe acute respiratory failure in the United States, 2008–2012. Ann Am Thorac Soc, 13: 2184–2189, 2016.
24.
BimeC, PouladiN, SammaniS, BataiK, CasanovaN, ZhouT, KempfCL, SunX, CampSM, WangT, KittlesRA, LussierYA, JonesTK, ReillyJP, MeyerNJ, ChristieJD, KarnesJ, Gonzalez-GarayM, ChristianiDC, YatesCR, WurfelMM, MeduriGU, and GarciaJGN. Genome wide association study in african americans with acute respiratory distress syndrome identifies the selectin p ligand gene as a risk factor. Am J Respir Crit Care Med, 197: 1421–1432, 2018.
25.
BimeC, ZhouT, WangT, SlepianMJ, GarciaJGN, and HeckerL. Reactive oxygen species-associated molecular signature predicts survival in patients with sepsis. Pulm Cir, 6: 196–201, 2016.
26.
BirukovKG, JacobsonJR, FloresAA, YeSQ, BirukovaAA, VerinAD, and GarciaJGN. Magnitude-dependent regulation of pulmonary endothelial cell barrier function by cyclic stretch. Am J Physiol Lung Cell Mol Physiol, 285: L785, 2003.
27.
BlondonnetR, ConstantinJ-M, SapinV, and JabaudonM. A pathophysiologic approach to biomarkers in acute respiratory distress syndrome. Dis Markers, 2016: 3501373, 2016.
28.
BourosD, AlexandrakisMG, AntoniouKM, AgouridakisP, PneumatikosI, AnevlavisS, PatakaA, PatlakasG, KarkavitsasN, and KyriakouD. The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for acute respiratory distress syndrome. BMC Pulm Med, 4: 6, 2004.
29.
BraunR.Systems analysis of high-throughput data. Adv Exp Med Biol, 844: 153–187, 2014.
30.
BrownSM, GrissomCK, RondinaMT, HoidalJR, ScholandMB, WolffRK, MorrisAH, PaineR, and NetworkNNA. Polymorphisms in key pulmonary inflammatory pathways and the development of acute respiratory distress syndrome. Exp Lung Res, 41: 155–162, 2015.
31.
BryanAC.Conference on the scientific basis of respiratory therapy. Pulmonary physiotherapy in the pediatric age group: comments of a devil's advocate. Am Rev Respir Dis, 110: 143–144, 1974.
32.
ButtY, KurdowskaA, and AllenTC. Acute lung injury: a clinical and molecular review. Arch Pathol Lab Med, 140: 345–350, 2016.
33.
CalfeeCS, DelucchiK, ParsonsPE, ThompsonBT, WareLB, MatthayMA, and NetworkNA. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med, 2: 611–620, 2014.
34.
CalfeeCS, GallagherD, AbbottJ, ThompsonBT, MatthayMA, and theNAN. Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Crit Care Med, 40: 1731–1737, 2012.
35.
CalfeeCS, WareLB, EisnerMD, ParsonsPE, ThompsonBT, WickershamN, MatthayMA, and NetworkNA. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax, 63: 1083–1089, 2008.
CarnesecchiS, Dunand-SauthierI, ZanettiF, SingovskiG, DeffertC, DonatiY, CagarelliT, PacheJ-C, KrauseK-H, ReithW, and Barazzone-ArgiroffoC. NOX1 is responsible for cell death through STAT3 activation in hyperoxia and is associated with the pathogenesis of acute respiratory distress syndrome. Int J Clin Exp Pathol, 7: 537–551, 2014.
38.
Cartin-CebaR, HubmayrRD, QinR, PetersS, DetermannRM, SchultzMJ, and GajicO. Predictive value of plasma biomarkers for mortality and organ failure development in patients with acute respiratory distress syndrome. J Crit Care, 30: 219.e211–219.e217, 2015.
39.
CeledónJC, BurchardEG, SchraufnagelD, Castillo-SalgadoC, SchenkerM, BalmesJ, NeptuneE, CummingsKJ, HolguinF, RiekertKA, WisniveskyJP, GarciaJGN, RomanJ, KittlesR, OrtegaVE, RedlineS, MathiasR, ThomasA, SametJ, FordJG, and American Thoracic Society and the National Heart LaBI. An American Thoracic Society/National Heart, Lung, and Blood Institute workshop report: addressing respiratory health equality in the United States. Ann Am Thorac Soc, 14: 814–826, 2017.
40.
ChangDW, HayashiS, GharibSA, VaisarT, KingST, TsuchiyaM, RuzinskiJT, ParkDR, Matute-BelloG, WurfelMM, BumgarnerR, HeineckeJW, and MartinTR. Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome. Am J Respir Crit Care Med, 178: 701–709, 2008.
41.
CheckleyW, MartinGS, BrownSM, ChangSY, DabbaghO, FremontRD, GirardTD, RiceTW, HowellMD, JohnsonSB, O'BrienJ, ParkPK, PastoresSM, PatilNT, PietropaoliAP, PutmanM, RotelloL, SinerJ, SajidS, MurphyDJ, SevranskyJE, and United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study I. Structure, process, and annual ICU mortality across 69 centers: United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study. Crit Care Med, 42: 344–356, 2014.
42.
ChenJ, ZhangZ, and CaiL. Diabetic cardiomyopathy and its prevention by nrf2: current status. Diab Metab J, 38: 337–345, 2014.
43.
ChiuL-C, TsaiF-C, HuH-C, ChangC-H, HungC-Y, LeeC-S, LiS-H, LinS-W, LiL-F, HuangC-C, ChenN-H, YangC-T, ChenY-C, and KaoK-C. Survival predictors in acute respiratory distress syndrome with extracorporeal membrane oxygenation. Ann Thorac Surg, 99: 243–250, 2015.
44.
ChoH-Y and KleebergerSR. Nrf2 protects against airway disorders. Toxicol Appl Pharmacol, 244: 43–56, 2010.
45.
ChowC-W, AbreuMTH, SuzukiT, and DowneyGP. Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol, 29: 427–431, 2003.
46.
ChowC-W, Herrera AbreuMT, SuzukiT, and DowneyGP. Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol, 29: 427–431, 2003.
47.
ChristieJD, MaSF, AplencR, LiM, LankenPN, ShahCV, FuchsB, AlbeldaSM, FloresC, and GarciaJG. Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma. Crit Care Med, 36: 2794–2800, 2008.
48.
ChristieJD, WurfelMM, FengR, O'KeefeGE, BradfieldJ, WareLB, ChristianiDC, CalfeeCS, CohenMJ, MatthayM, MeyerNJ, KimC, LiM, AkeyJ, BarnesKC, SevranskyJ, LankenPN, MayAK, AplencR, MaloneyJP, HakonarsonH, and for the Trauma ALISNPCi. Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major trauma. PLoS One, 7: e28268, 2012.
49.
ChungH-F, LongKZ, HsuC-C, MamunAA, ChiuY-F, TuH-P, ChenP-S, JhangH-R, HwangS-J, and HuangM-C. Adiponectin gene (ADIPOQ) polymorphisms correlate with the progression of nephropathy in Taiwanese male patients with type 2 diabetes. Diab Res Clin Pract, 105: 261–270, 2014.
50.
CochiSE, KempkerJA, AnnangiS, KramerMR, and MartinGS. Mortality trends of acute respiratory distress syndrome in the United States from 1999 to 2013. Ann Am Thorac Soc, 13: 1742–1751, 2016.
51.
CohenMJ, BrohiK, CalfeeCS, RahnP, ChesebroBB, ChristiaansSC, Christiaans, CarlesM, HowardM, PittetJ-F. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care, 13: R174, 2009.
52.
CookeCR, EricksonSE, EisnerMD, and MartinGS. Trends in the incidence of noncardiogenic acute respiratory failure: the role of race. Crit Care Med, 40: 1532–1538, 2012.
53.
D'AlessioFR, CraigJM, SingerBD, FilesDC, MockJR, GaribaldiBT, FallicaJ, TripathiA, MandkeP, GansJH, LimjunyawongN, SidhayeVK, HellerNM, MitznerW, KingLS, and AggarwalNR. Enhanced resolution of experimental ARDS through IL-4-mediated lung macrophage reprogramming. Am J Physiol Lung Cell Mol Physiol, 310: L733–L746, 2016.
54.
DevaneyJ, ContrerasM, and LaffeyJG. Clinical review: gene-based therapies for ALI/ARDS: where are we now?. Crit Care, 15: 224, 2011.
DinarelloCA.Biologic basis for interleukin-1 in disease. Blood, 87: 2095, 1996.
57.
DoyleIR, HermansC, BernardA, NicholasTE, and BerstenAD. Clearance of clara cell secretory protein 16 (CC16) and surfactant proteins A and B from blood in acute respiratory failure. Am J Respir Crit Care Med, 158: 1528–1535, 1998.
58.
DreyfussD and SaumonG. Ventilator-induced lung injury. Am J Respir Crit Care Med, 157: 294–323, 1998.
59.
DuP, ZhangX, HuangC-C, JafariN, KibbeWA, HouL, and LinSM. Comparison of beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics, 11: 587, 2010.
60.
DudekSM and GarciaJGN. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol, 91: 1487–1500, 2001.
61.
DustinML, RothleinR, BhanAK, DinarelloCA, and SpringerTA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). 137: 245–254, 1986.
62.
DötschA, EiseleL, RabelingM, RumpK, WalsteinK, BickA, CoxL, EnglerA, BachmannHS, JöckelK-H, AdamzikM, PetersJ, and SchäferST. Hypoxia inducible factor-2 alpha and prolinhydroxylase 2 polymorphisms in patients with acute respiratory distress syndrome (ARDS). Int J Mol Sci, 18: 1266, 2017.
63.
EklundL and SaharinenP. Angiopoietin signaling in the vasculature. Exp Cell Res, 319: 1271–1280, 2013.
64.
ElangovanVR, CampSM, KellyGT, DesaiAA, AdyshevD, SunX, BlackSM, WangT, and GarciaJGN. Endotoxin- and mechanical stress-induced epigenetic changes in the regulation of the nicotinamide phosphoribosyltransferase promoter. Pulm Circ, 6: 539–544, 2016.
65.
EricksonSE, ShlipakMG, MartinGS, WheelerAP, AncukiewiczM, MatthayMA, and EisnerMD. Racial and ethnic disparities in mortality from acute lung injury. Crit Care Med, 37: 1–6, 2009.
66.
FamousKR, DelucchiK, WareLB, KangelarisKN, LiuKD, ThompsonBT, and CalfeeCS. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med, 195: 331–338, 2016.
67.
FloresC, del Mar Pino-YanesM, and VillarJ. A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury. Crit Care, 12: R130, 2008.
68.
FloresC, MaS, MaressoK, OberC, and GarciaJ. A variant of the myosin light chain kinase gene is associated with severe asthma in African Americans. Genet Epidemiol, 41: 4, 2007.
69.
FloresC, MaS-F, MaressoK, WadeMS, VillarJ, and GarciaJGN. IL6 gene-wide haplotype is associated with susceptibility to acute lung injury. Transl Res, 152: 11–17, 2008.
70.
FloresC, Pérez-MéndezL, Maca-MeyerN, MurielA, EspinosaE, BlancoJ, SangüesaR, MurosM, GarciaJGN, and VillarJ. A common haplotype of the LBP gene predisposes to severe sepsis. Crit Care Med, 37: 2759–2766, 2009.
71.
FrankAJ and ThompsonBT. Pharmacological treatments for acute respiratory distress syndrome. Curr Opin Crit Care, 16: 62–68, 2010.
GaoL, GrantA, HalderI, BrowerR, SevranskyJ, MaloneyJP, MossM, ShanholtzC, YatesCR, MeduriGU, ShriverMD, IngersollR, ScottAF, BeatyTH, MoitraJ, MaSF, YeSQ, BarnesKC, and GarciaJGN. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol, 34: 487–495, 2006.
74.
GaoL, GrantAV, RafaelsN, Stockton-PorterM, WatkinsT, GaoP, ChiP, MuñozM, WatsonH, DunstonG, TogiasA, HanselN, SevranskyJ, MaloneyJP, MossM, ShanholtzC, BrowerR, GarciaJGN, GrigoryevDN, CheadleC, BeatyTH, MathiasRA, and BarnesKC. Polymorphisms in the myosin light chain kinase gene that confer risk of severe sepsis are associated with a lower risk of asthma. J Allergy Clin Immunol, 119: 1111–1118, 2007.
75.
GaoL, TsaiYJ, GrigoryevDN, and BarnesKC. Host defense genes in asthma and sepsis and the role of the environment. Curr Opin Allergy Clin Immunol, 7: 459–467, 2007.
76.
GarciaJGN and SznajderJI. Healthcare disparities in patients with acute respiratory distress syndrome. toward equity. Am J Respir Crit Care Med, 188: 631–632, 2013.
77.
GarciaJGN, VerinAD, and SchaphorstKL. Regulation of thrombin-mediated endothelial cell contraction and permeability. Semin Thromb Hemost, 22: 309–315, 1996.
78.
GhoshCC, DavidS, ZhangR, BerghelliA, MilamK, HigginsSJ, HunterJ, MukherjeeA, WeiY, TranM, SuberF, KobzikL, KainKC, LuS, SantelA, YanoK, GuhaP, DumontDJ, ChristianiDC, and ParikhSM. Gene control of tyrosine kinase TIE2 and vascular manifestations of infections. Proc Natl Acad Sci U S A, 113: 2472, 2016.
79.
GianfrancescoF, RendinaD, Di StefanoM, MingioneA, EspositoT, MerlottiD, GalloneS, MaglioccaS, GoodeA, FormicolaD, MorelloG, LayfieldR, FrattiniA, De FilippoG, NutiR, SearleM, StrazzulloP, IsaiaG, MossettiG, and GennariL. A nonsynonymous TNFRSF11A variation increases NFκB activity and the severity of Paget's disease. J Bone Miner Res, 27: 443–452, 2011.
80.
GoldmanJL, SammaniS, KempfC, SaadatL, LetsiouE, WangT, Moreno-VinascoL, RizzoAN, FortmanJD, and GarciaJGN. Pleiotropic effects of interleukin-6 in a “two-hit” murine model of acute respiratory distress syndrome. Pulm Circ, 4: 280–288, 2014.
81.
GongMN, WeiZ, XuL-L, MillerDP, ThompsonBT, and ChristianiDC. Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest, 125: 203–211, 2004.
82.
GriffithB, PendyalaS, HeckerL, LeePJ, NatarajanV, and ThannickalVJ. NOX enzymes and pulmonary disease. Antioxid Redox Signal, 11: 2505–2516, 2009.
83.
GrigoryevDN, FiniganJH, HassounP, and GarciaJGN. Science review: searching for gene candidates in acute lung injury. Crit Care, 8: 440–447, 2004.
84.
GrigoryevDN, MaS-F, IrizarryRA, YeSQ, QuackenbushJ, and GarciaJGN. Orthologous gene-expression profiling in multi-species models: search for candidate genes. Genome Biol, 5: R34, 2004.
85.
GrommesJ and SoehnleinO. Contribution of neutrophils to acute lung injury. Mol Med, 17: 293–307, 2011.
86.
HeadleyAS, MeduriGU, and TolleyE. Infections and the inflammatory response in acute respiratory distress syndrome. Chest, 111: 1306–1321, 1997.
87.
HeckerL, VittalR, JonesT, JagirdarR, LuckhardtTR, HorowitzJC, PennathurS, MartinezFJ, and ThannickalVJ. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med, 15: 1077–1081, 2009.
88.
Hernandez-PachecoN, Guillen-GuioB, Acosta-HerreraM, Pino-YanesM, CorralesA, AmbrosA, NogalesL, MurielA, Gonzalez-HiguerasE, Diaz-DominguezFJ, ZavalaE, BeldaJ, MaSF, VillarJ, and FloresC. A vascular endothelial growth factor receptor gene variant is associated with susceptibility to acute respiratory distress syndrome. Intens Care Med Exp, 6: 16, 2018.
89.
HerwigR, HardtC, LienhardM, and KamburovA. Analyzing and interpreting genome data at the network level with ConsensusPathDB. Nat Protoc, 11: 1889, 2016.
90.
HinzJ, BüttnerB, KrieselF, SteinauM, Frederik PopovA, GhadimiM, BeissbarthT, TzvetkovM, BergmannI, and MansurA. The FER rs4957796 TT genotype is associated with unfavorable 90-day survival in Caucasian patients with severe ARDS due to pneumonia. Sci Rep, 7: 9887, 2017.
91.
HongS-B, HuangY, Moreno-VinascoL, SammaniS, MoitraJ, BarnardJW, MaS-F, MirzapoiazovaT, EvenoskiC, ReevesRR, ChiangET, LangGD, HusainAN, DudekSM, JacobsonJR, YeSQ, LussierYA, and GarciaJGN. Essential role of pre-B-cell colony enhancing factor in ventilator-induced lung injury. Am J Respir Crit Care Med, 178: 605–617, 2008.
92.
HästbackaJ, LinkoR, TervahartialaT, VarpulaT, HovilehtoS, ParviainenI, VaaraST, SorsaT, and PettiläV. Serum MMP-8 and TIMP-1 in critically ill patients with acute respiratory failure: TIMP-1 is associated with increased 90-day mortality. Anesth Analg, 118: 790–798, 2014.
93.
ImaiY, KubaK, NeelyGG, Yaghubian-MalhamiR, PerkmannT, van LooG, ErmolaevaM, VeldhuizenR, LeungYHC, WangH, LiuH, SunY, PasparakisM, KopfM, MechC, BavariS, PeirisJSM, SlutskyAS, AkiraS, HultqvistM, HolmdahlR, NichollsJ, JiangC, BinderCJ, and PenningerJM. Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell, 133: 235–249, 2008.
94.
JabaudonM, BerthelinP, PranalT, RoszykL, GodetT, FaureJ-S, ChabanneR, EisenmannN, LautretteA, BelvilleC, BlondonnetR, CayotS, GillartT, PascalJ, SkrzypczakY, SouweineB, BlanchonL, SapinV, PereiraB, and ConstantinJ-M. Receptor for advanced glycation end-products and ARDS prediction: a multicentre observational study. Sci Rep, 8: 2603, 2018.
95.
JabaudonM, BlondonnetR, RoszykL, BouvierD, AudardJ, ClairefondG, FournierM, MarceauG, DéchelotteP, PereiraB, SapinV, and ConstantinJ-M. Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome. Am J Respir Crit Care Med, 192: 191–199, 2015.
96.
JabaudonM, BlondonnetR, RoszykL, PereiraB, GuérinR, PerbetS, CayotS, BouvierD, BlanchonL, SapinV, and ConstantinJ-M. soluble forms and ligands of the receptor for advanced glycation end-products in patients with acute respiratory distress syndrome: an observational prospective study. PLoS One, 10: e0135857, 2015.
97.
JabaudonM, FutierE, RoszykL, ChalusE, GuerinR, PetitA, MrozekS, PerbetS, Cayot-ConstantinS, ChartierC, SapinV, BazinJ-E, and ConstantinJ-M. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med, 39: 480–488, 2011.
98.
JabaudonM, FutierE, RoszykL, SapinV, PereiraB, and ConstantinJ-M. Association between intraoperative ventilator settings and plasma levels of soluble receptor for advanced glycation end-products in patients without pre-existing lung injury. Respirology, 20: 1131–1138, 2015.
99.
JanzDR and WareLB. Biomarkers of ALI/ARDS: pathogenesis, discovery, and relevance to clinical trials. Semin Respir Crit Care Med, 34: 537–548, 2013.
100.
JiaSH, LiY, ParodoJ, KapusA, FanL, RotsteinOD, and MarshallJC. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest, 113: 1318–1327, 2004.
101.
JinL, ZuoX-Y, SuW-Y, ZhaoX-L, YuanM-Q, HanL-Z, ZhaoX, ChenY-D, and RaoS-Q. Pathway-based analysis tools for complex diseases: a review. Genomics Proteomics Bioinformatics, 12: 210–220, 2014.
102.
KalletRH, ZhuoH, HoK, LipnickMS, GomezA, and MatthayMA. Lung injury etiology and other factors influencing the relationship between dead-space fraction and mortality in ARDS. Respir Care, 62: 1241, 2017.
103.
KamburovA, PentchevK, GalickaH, WierlingC, LehrachH, and HerwigR. ConsensusPathDB: toward a more complete picture of cell biology. Nucleic Acids Res, 39: D712–D717, 2011.
104.
KamburovA, StelzlU, LehrachH, and HerwigR. The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res, 41: D793–D800, 2013.
105.
KangelarisKN, CalfeeCS, MayAK, ZhuoH, MatthayMA, and WareLB. Is there still a role for the lung injury score in the era of the Berlin definition ARDS?. Ann Intens Care, 4: 4, 2014.
106.
KangelarisKN, PrakashA, LiuKD, AouizeratB, WoodruffPG, ErleDJ, RogersA, SeeleyEJ, ChuJ, LiuT, Osterberg-DeissT, ZhuoH, MatthayMA, and CalfeeCS. Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. Am J Physiol Lung Cell Mol Physiol, 308: L1102–L1113, 2015.
107.
KovachMA, StringerKA, BuntingR, WuX, San MateoL, NewsteadMW, PaineR, and StandifordTJ. Microarray analysis identifies IL-1 receptor type 2 as a novel candidate biomarker in patients with acute respiratory distress syndrome. Respir Res, 16: 29, 2015.
108.
LaffeyJG and KavanaghBP. Fifty years of research in ARDS. Insight into acute respiratory distress syndrome. from models to patients. Am J Respir Crit Care Med, 196: 18–28, 2017.
109.
LeeK, HuhJW, LimC-M, KohY, and HongS-B. Clinical role of serum pre-B cell colony-enhancing factor in ventilated patients with sepsis and acute respiratory distress syndrome. Scand J Infect Dis, 45: 760–765, 2013.
110.
LeeY-L, ChenW, ChenL-Y, ChenC-H, LinY-C, LiangS-J, and ShihC-M. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia. J Cri Care, 25: 176.e7–176.e13, 2010.
111.
LiG, MalinchocM, Cartin-CebaR, VenkataCV, KorDJ, PetersSG, HubmayrRD, and GajicO. Eight-year trend of acute respiratory distress syndrome. Am J Respir Crit Care Med, 183: 59–66, 2011.
112.
LinZ, PearsonC, ChinchilliV, PietschmannSM, LuoJ, PisonU, and FlorosJ. Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet, 58: 181–191, 2001.
113.
LiuH, ZhangD, ZhaoB, and ZhaoJ. Superoxide anion, the main species of ROS in the development of ARDS induced by oleic acid. Free Radic Res, 38: 1281–1287, 2004.
114.
LiuP, Rojo de la VegaM, SammaniS, MascarenhasJ, KerinsM, DodsonM, SunX, WangT, OoiA, GarciaJ, and ZhangD. MYLK transcriptional repression by NRF2-ARE and RPA1 enhances vascular integrity. Proc Natl Acad Sci U S A, 115:E10352–E10361, 2018.
115.
LuJ-F, ZhouY, HuangG-H, JiangH-X, HuB-L, and QinS-Y. Association of ADIPOQ polymorphisms with obesity risk: a meta-analysis. Hum Immunol, 75: 1062–1068, 2014.
116.
MaS-F, XieL, Pino-YanesM, SammaniS, WadeMS, LetsiouE, SieglerJ, WangT, InfusinoG, KittlesRA, FloresC, ZhouT, PrabhakarBS, Moreno-VinascoL, VillarJ, JacobsonJR, DudekSM, and GarciaJGN. Type 2 deiodinase and host responses of sepsis and acute lung injury. Am J Respir Cell Mol Biol, 45: 1203–1211, 2011.
117.
MarshallRP, WebbS, BellinganGJ, MontgomeryHE, ChaudhariB, McAnultyRJ, HumphriesSE, HillMR, and LaurentGJ. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med, 166: 646–650, 2002.
118.
MarshallRP, WebbS, HillMR, HumphriesSE, and LaurentGJ. Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest, 121: 68S–69S, 2002.
119.
Martín-LoechesI, Solé-ViolánJ, Rodríguez de CastroF, García-LaordenMI, BorderíasL, BlanquerJ, RajasO, BrionesML, AspaJ, Herrera-RamosE, Marcos-RamosJA, SologurenI, González-QuevedoN, Ferrer-AgüeroJM, NodaJ, and Rodríguez-GallegoC. Variants at the promoter of the interleukin-6 gene are associated with severity and outcome of pneumococcal community-acquired pneumonia. Intens Care Med, 38: 256–262, 2012.
120.
MascarenhasJB, TchourbanovAY, FanH, DanilovSM, WangT, and GarciaJGN. Mechanical stress and single nucleotide variants regulate alternative splicing of the MYLK gene. Am J Respir Cell Mol Biol, 56: 29–37, 2016.
121.
MeduriGU, HeadleyS, KohlerG, StentzF, TolleyE, UmbergerR, and LeeperK. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time. Chest, 107: 1062–1073, 1995.
122.
MehtaNN, HeffronSP, PatelPN, FergusonJ, ShahRD, HinkleCC, KrishnamoorthyP, ShahR, Tabita-MartinezJ, TerembulaK, MasterSR, RickelsMR, and ReillyMP. A human model of inflammatory cardio-metabolic dysfunction; a double blind placebo-controlled crossover trial. J Transl Med, 10: 124, 2012.
123.
MeyerNJ.Beyond SNPs—genetics, genomics and other ‘omic approaches to ARDS. Clin Chest Med, 35: 673–684, 2014.
124.
MeyerNJ, FengR, LiM, ZhaoY, SheuC-C, TejeraP, GallopR, BellamyS, RushefskiM, LankenPN, AplencR, O'KeefeGE, WurfelMM, ChristianiDC, and ChristieJD. IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist. Am J Respir Crit Care Med, 187: 950–959, 2013.
125.
MeyerNJ, HuangY, SingletonPA, SammaniS, MoitraJ, EvenoskiCL, HusainAN, MitraS, Moreno-VinascoL, JacobsonJR, LussierYA, and GarciaJGN. GADD45a is a novel candidate gene in inflammatory lung injury via influences on Akt signaling. FASEB J, 23: 1325–1337, 2009.
126.
MirzapoiazovaT, MoitraJ, Moreno-VinascoL, SammaniS, TurnerJR, ChiangET, EvenoskiC, WangT, SingletonPA, HuangY, LussierYA, WattersonDM, DudekSM, and GarciaJGN. Muscle myosin light chain kinase isoform is a viable molecular target in acute inflammatory lung injury. Am J Respir Cell Mol Biol, 44: 40–52, 2009.
127.
MitraS, WadeMS, SunX, MoldobaevaN, FloresC, MaS-F, ZhangW, GarciaJGN, and JacobsonJR. GADD45a promoter regulation by a functional genetic variant associated with acute lung injury. PLoS One, 9: e100169, 2014.
128.
Moreno-VinascoL, QuijadaH, SammaniS, SieglerJ, LetsiouE, DeatonR, SaadatL, ZaidiRS, MessanaJ, GannPH, MachadoRF, MaW, CampSM, WangT, and GarciaJGN. nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury. Am J Respir Cell Mol Biol, 51: 223–228, 2014.
129.
MorrellED, O'MahonyDS, GlavanBJ, Harju-BakerS, NguyenC, GundersonS, AbrahamsonA, RadellaF, RonaG, BlackRA, and WurfelMM. Genetic variation in MAP3K1 associates with ventilator-free days in acute respiratory distress syndrome. Am J Respir Cell Mol Biol, 58: 117–125, 2017.
130.
MossM and ManninoDM. Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979–1996). Crit Care Med, 30: 1679–1685, 2002.
131.
MurrayJF, MatthayMA, LuceJM, and FlickMR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis, 138: 720–723, 1988.
132.
NakamuraT, SatoE, FujiwaraN, KawagoeY, MaedaS, and YamagishiS-I. Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome. Clin Biochem, 44: 601–604, 2011.
133.
NatarajanV, DudekSM, JacobsonJR, Moreno-VinascoL, HuangLS, AbassiT, MathewB, ZhaoY, WangL, BittmanR, WeichselbaumR, BerdyshevE, and GarciaJGN. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. Am J Respir Cell Mol Biol, 49: 6–17, 2013.
134.
NeeperM, SchmidtAM, BrettJ, YanSD, WangF, PanYC, EllistonK, SternD, and ShawA. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem, 267: 14998–15004, 1992.
135.
NickJA, CaceresSM, KretJE, PochKR, StrandM, FainoAV, NicholsDP, SaavedraMT, Taylor-CousarJL, GeraciMW, BurnhamEL, FesslerMB, SurattBT, AbrahamE, MossM, and MalcolmKC. Extremes of interferon-stimulated gene expression associate with worse outcomes in the acute respiratory distress syndrome. PLoS One, 11: e0162490, 2016.
136.
O'MahonyDS, GlavanBJ, HoldenTD, FongC, BlackRA, RonaG, TejeraP, ChristianiDC, and WurfelMM. Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation study. PLoS One, 7: e51104, 2012.
137.
O'SheaJJ and PlengeR.JAKs and STATs in immunoregulation and immune-mediated disease. Immunity, 36: 542–550, 2012
138.
This reference has been deleted.
139.
OzolinaA, SarkeleM, SabelnikovsO, SkestersA, JaunalksneI, SerovaJ, IevinsT, BjertnaesLJ, and VanagsI. Activation of coagulation and fibrinolysis in acute respiratory distress syndrome: a prospective pilot study. Front Med, 3: 64, 2016.
140.
This reference has been deleted.
141.
ParkJ-B, NagarH, ChoiS, JungS-B, KimH-W, KangSK, LeeJW, LeeJH, ParkJ-W, IraniK, JeonBH, SongH-J, and KimC-S. IDH2 deficiency impairs mitochondrial function in endothelial cells and endothelium-dependent vasomotor function. Free Radic Biol Med, 94: 36–46, 2016.
142.
ParsonsPE, MossM, VanniceJL, MooreEE, MooreFA, and RepineJE. Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. Am J Respir Crit Care Med, 155: 1469–1473, 1997.
143.
PendyalaS, MoitraJ, KalariS, KleebergerSR, ZhaoY, ReddySP, GarciaJGN, and NatarajanV. NRF2 Regulates hyperoxia-induced NOX4 expression in human lung endothelium: identification of functional antioxidant response elements on NOX4 promoter. Free Radic Biol Med, 50: 1749–1759, 2011.
144.
Pino-YanesM, MaS-F, SunX, TejeraP, CorralesA, BlancoJ, Pérez-MéndezL, EspinosaE, MurielA, BlanchL, GarciaJGN, VillarJ, and FloresC. Interleukin-1 receptor-associated kinase 3 gene associates with susceptibility to acute lung injury. Am J Respir Cell Mol Biol, 45: 740–745, 2011.
145.
PociotF, MØLvigJ, WogensenL, WorsaaeH, and NerupJ. A Taql polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest, 22: 396–402, 1992.
146.
PrabhakaranP, WareLB, WhiteKE, CrossMT, MatthayMA, and OlmanMA. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol, 285: L20–L28, 2003.
QayyumR, SnivelyBM, ZivE, NallsMA, LiuY, TangW, YanekLR, LangeL, EvansMK, GaneshS, AustinMA, LettreG, BeckerDM, ZondermanAB, SingletonAB, HarrisTB, MohlerER, LogsdonBA, KooperbergC, FolsomAR, WilsonJG, BeckerLC, and ReinerAP. A meta-analysis and genome-wide association study of platelet count and mean platelet volume in African Americans. PLOS Genet, 8: e1002491, 2012.
149.
QiD, WangD, ZhangC, TangX, HeJ, ZhaoY, DengW, and DengX. Vaspin protects against LPS-induced ARDS by inhibiting inflammation, apoptosis and reactive oxygen species generation in pulmonary endothelial cells via the Akt/GSK-3β pathway. Int J Mol Med, 40: 1803–1817, 2017.
150.
RautanenA, MillsTC, GordonAC, HuttonP, SteffensM, NuamahR, ChicheJ-D, ParksT, ChapmanSJ, DavenportEE, ElliottKS, BionJ, LichtnerP, MeitingerT, WienkerTF, CaulfieldMJ, MeinC, BloosF, BobekI, CotogniP, SramekV, SarapuuS, KobilayM, RanieriVM, RelloJ, SirgoG, WeissYG, RusswurmS, SchneiderEM, ReinhartK, HollowayPAH, KnightJC, GarrardCS, RussellJA, WalleyKR, StüberF, HillAVS, HindsCJ, and for theEEGI. Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study. Lancet Respir Med, 3: 53–60, 2015.
151.
ReillyJP, ChristieJD, and MeyerNJ. Fifty years of research in ARDS. Genomic contributions and opportunities. Am J Respir Crit Care Med, 196: 1113–1121, 2017.
152.
Rojo de la VegaM, DodsonM, GrossC, ManzourH, LantzRC, ChapmanE, WangT, BlackSM, GarciaJGN, and ZhangDD. Role of Nrf2 and autophagy in acute lung injury. Curr Pharmacol Rep, 2: 91–101, 2016.
153.
RubenfeldGD, CaldwellE, PeabodyE, WeaverJ, MartinDP, NeffM, SternEJ, and HudsonLD. Incidence and outcomes of acute lung injury. N Engl J Med, 353: 1685–1693, 2005.
154.
RuhlAP, HuangM, ColantuoniE, KarmarkarT, DinglasVD, HopkinsRO, NeedhamDM, and with the National Institutes ofHealth, NationalHeart, Lung, and Blood Institute Acute Respiratory Distress SyndromeNetwork. Healthcare utilization and costs in ARDS survivors: a 1-year longitudinal national US multicenter study. Intensive Care Med, 43: 980–991, 2017.
155.
RyuH, LeeJ, ZamanK, KubilisJ, FerranteRJ, RossBD, NeveR, and RatanRR. Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J Neurosci, 23: 3597, 2003.
156.
SalnikovaLE, SmelayaTV, VesninaIN, GolubevAM, and MorozVV. Genetic susceptibility to nosocomial pneumonia, acute respiratory distress syndrome and poor outcome in patients at risk of critical illness. Inflammation, 37: 295–305, 2014.
157.
SammaniS, Moreno-VinascoL, MirzapoiazovaT, SingletonPA, ChiangET, EvenoskiCL, WangT, MathewB, HusainA, MoitraJ, SunX, NunezL, JacobsonJR, DudekSM, NatarajanV, and GarciaJGN. Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung. Am J Respir Cell Mol Biol, 43: 394–402, 2010.
158.
ShaverCM and BastaracheJA. Clinical and biological heterogeneity in ARDS: direct versus indirect lung injury. Clin Chest Med, 35: 639–653, 2014.
159.
ShenK, RamirezB, MapesB, ShenGR, GokhaleV, BrownME, SantarsieroB, IshiiY, DudekSM, WangT, and GarciaJGN. Structure–function analysis of the non-muscle myosin light chain kinase (nmMLCK) isoform by NMR spectroscopy and molecular modeling: influence of MYLK variants. PLoS One, 10: e0130515, 2015.
160.
SheuCC, ZhaiR, SuL, TejeraP, GongMN, ThompsonBT, ChenF, and ChristianiDC. Sex-specific association of epidermal growth factor gene polymorphisms with ARDS. Eur Respir J, 33: 543–550, 2009.
161.
ShibuyaM.Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem, 153: 13–19, 2013.
162.
ShimizuY, CampSM, SunX, ZhouT, WangT, and GarciaJGN. Sp1-mediated nonmuscle myosin light chain kinase expression and enhanced activity in vascular endothelial growth factor-induced vascular permeability. Pulm Circ, 5: 707–715, 2015.
163.
ShirasawaM, FujiwaraN, HirabayashiS, OhnoH, IidaJ, MakitaK, and HataY. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells, 9: 165–174, 2004.
164.
ShorttK, ChaudharyS, GrigoryevD, HeruthDP, VenkitachalamL, ZhangLQ, and YeSQ. Identification of novel single nucleotide polymorphisms associated with acute respiratory distress syndrome by exome-seq. PLoS One, 9: e111953, 2014.
165.
SimonBA, EasleyRB, GrigoryevDN, MaS-F, YeSQ, LavoieT, TuderRM, and GarciaJGN. Microarray analysis of regional cellular responses to local mechanical stress in acute lung injury. Am J Physiol Lung Cell Mol Physiol, 291: L851–L861, 2006.
166.
This reference has been deleted.
167.
SirinianC, PapanastasiouAD, ZarkadisIK, and KalofonosHP. Alternative splicing generates a truncated isoform of human TNFRSF11A (RANK) with an altered capacity to activate NF-κB. Gene, 525: 124–129, 2013.
168.
SoubrierF, ChungWK, MachadoR, GrünigE, AldredM, GeraciM, LoydJE, ElliottCG, TrembathRC, NewmanJH, and HumbertM. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol, 62: D13–D21, 2013.
169.
SteinbergK, HudsonL, GoodmanR, HoughC, LankenP, HyzyR, ThompsonB, AncukiewiczM, and National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med, 354: 1671–1684, 2006.
170.
SunX, ElangovanVR, MapesB, CampSM, SammaniS, SaadatL, CecoE, MaS-F, FloresC, MacDougallMS, QuijadaH, LiuB, KempfCL, WangT, ChiangET, and GarciaJGN. The NAMPT promoter is regulated by mechanical stress, signal transducer and activator of transcription 5, and acute respiratory distress syndrome-associated genetic variants. Am J Respir Cell Mol Biol, 51: 660–667, 2014.
171.
SunX, MaS-F, WadeMS, Acosta-HerreraM, VillarJ, Pino-YanesM, ZhouT, LiuB, BelvitchP, MoitraJ, HanY-J, MachadoR, NothI, NatarajanV, DudekSM, JacobsonJR, FloresC, and GarciaJGN. Functional promoter variants in sphingosine 1-phosphate receptor 3 associate with susceptibility to sepsis-associated acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol, 305: L467–L477, 2013.
172.
SunX, SingletonPA, LetsiouE, ZhaoJ, BelvitchP, SammaniS, ChiangET, Moreno-VinascoL, WadeMS, ZhouT, LiuB, ParastatidisI, ThomsonL, IschiropoulosH, NatarajanV, JacobsonJR, MachadoRF, DudekSM, and GarciaJGN. Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury. Am J Respir Cell Mol Biol, 47: 628–636, 2012.
173.
SuterPM, FairleyHB, and IsenbergMD. Optimum end-expiratory airway pressure in patients with acute pulmonary failure. N Engl J Med, 292: 284–289, 1975.
174.
TaoS, Rojo de la VegaM, QuijadaH, WondrakGT, WangT, GarciaJGN, and ZhangDD. Bixin protects mice against ventilation-induced lung injury in an NRF2-dependent manner. Sci Rep, 6: 18760, 2016.
175.
TejeraP, MeyerN, ChenF, FengR, ZhaoY, O'MahonyDS, LiL, SheuC-C, ZhaiR, WangZ, SuL, BajwaE, AhasicAM, ClardyP, GongMN, FrankAJ, LankenPN, ThompsonBT, ChristieJD, WurfelM, O'KeefeG, and ChristianiDC. Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin. J Med Genet, 49: 671–680, 2012.
176.
TejeraP, WangZ, ZhaiR, SuL, SheuC-C, TaylorDM, ChenF, GongMN, ThompsonBT, and ChristianiDC. Genetic polymorphisms of peptidase inhibitor 3 (Elafin) are associated with acute respiratory distress syndrome. Am J Respir Cell Mol Biol, 41: 696–704, 2009.
177.
TerpstraML, AmanJ, van Nieuw AmerongenGP, and GroeneveldABJ. Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med, 42: 691–700, 2014.
178.
TheADTF.Acute respiratory distress syndrome: the berlin definition. JAMA, 307: 2526–2533, 2012.
179.
TiretL, RigatB, VisvikisS, BredaC, CorvolP, CambienF, and SoubrierF. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet, 51: 197–205, 1992.
180.
TsaiM-K, WangH-MD, ShiangJ-C, ChenIH, WangC-C, ShiaoY-F, LiuW-S, LinT-J, ChenT-M, and ChenY-H. Sequence variants of ADIPOQ and association with type 2 diabetes mellitus in Taiwan Chinese Han population. Sci World J, 2014: 650393, 2014.
181.
UchidaT, ShirasawaM, WareLB, KojimaK, HataY, MakitaK, MednickG, MatthayZA, and MatthayMA. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med, 173: 1008–1015, 2006.
182.
van den BorstB, SourenNY, GielenM, LoosRJF, PaulussenADC, DeromC, ScholsAMWJ, and ZeegersMPA. Association between the IL6-174G/C SNP and maximally attained lung function. Thorax, 66: 179, 2011.
183.
VarleyI, HughesDC, GreevesJP, StellingwerffT, RansonC, FraserWD, and SaleC. RANK/RANKL/OPG pathway: genetic associations with stress fracture period prevalence in elite athletes. Bone, 71: 131–136, 2015.
184.
VillarinoAV, KannoY, and O'SheaJJ. Mechanisms of Jak/STAT signaling in immunity and disease. J Immunol, 194: 21–27, 2015.
185.
WacharasintP, NakadaTA, Boyd JohnH, Russell JamesA, and Walley KeithR. AA genotype of IL-8–251A/T is associated with low PaO2/FiO2 in critically ill patients and with increased IL-8 expression. Respirology, 17: 1253–1260, 2012.
186.
WangH, BloomO, ZhangM, VishnubhakatJM, OmbrellinoM, CheJ, FrazierA, YangH, IvanovaS, BorovikovaL, ManogueKR, FaistE, AbrahamE, AnderssonJ, AnderssonU, MolinaPE, AbumradNN, SamaA, and TraceyKJ. HMG-1 as a late mediator of endotoxin lethality in mice. Science, 285: 248, 1999.
187.
WangH-W, YangW, LuJ-Y, LiF, SunJ-Z, ZhangW, GuoN-N, GaoL, and KangJ-R. N-acetylcysteine administration is associated with reduced activation of NF-kB and preserves lung dendritic cells function in a zymosan-induced generalized inflammation model. J Clin Immunol, 33: 649–660, 2013.
188.
WangM, YanJ, HeX, ZhongQ, ZhanC, and LiS. Candidate genes and pathogenesis investigation for sepsis-related acute respiratory distress syndrome based on gene expression profile. Biol Res, 49: 25, 2016.
189.
WangT, BrownME, KellyGT, CampSM, MascarenhasJB, SunX, DudekSM, and GarciaJGN. Myosin light chain kinase (MYLK) coding polymorphisms modulate human lung endothelial cell barrier responses via altered tyrosine phosphorylation, spatial localization, and lamellipodial protrusions. Pulm Circ, 8: 2045894018764171, 2018.
190.
WangZ, BeachD, SuL, ZhaiR, and ChristianiDC. A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS. Am J Respir Cell Mol Biol, 38: 724–732, 2008.
191.
WareLB.Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med, 33: S217–S222, 2005.
192.
WareLB, KoyamaT, BillheimerDD, WuW, BernardGR, ThompsonBT, BrowerRG, StandifordTJ, MartinTR, MatthayMA, and NetworkNACT. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest, 137: 288–296, 2010.
193.
WareLB, KoyamaT, ZhaoZ, JanzDR, WickershamN, BernardGR, MayAK, CalfeeCS, and MatthayMA. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care, 17: R253, 2013.
194.
WeiY, TejeraP, WangZ, ZhangR, ChenF, SuL, LinX, BajwaEK, ThompsonBT, and ChristianiDC. A missense genetic variant in LRRC16A/CARMIL1 improves acute respiratory distress syndrome survival by attenuating platelet count decline. Am J Respir Crit Care Med, 195: 1353–1361, 2016.
195.
WeiY, WangZ, SuL, ChenF, TejeraP, BajwaEK, WurfelMM, LinX, and ChristianiDC. Platelet count mediates the contribution of a genetic variant in LRRC 16A to ARDS risk. Chest, 147: 607–617, 2015.
196.
WolfsonRK, MapesB, and GarciaJGN. Excessive mechanical stress increases HMGB1 expression in human lung microvascular endothelial cells via STAT3. Microvasc Res, 92: 50–55, 2014.
197.
WuJ, LiuZ, MengK, and ZhangL. Association of adiponectin gene (ADIPOQ) rs2241766 polymorphism with obesity in adults: a meta-analysis. PLoS One, 9: e95270, 2014.
198.
WurfelMM.Microarray-based analysis of ventilator-induced lung injury. Proc Am Thorac Soc, 4: 77–84, 2007.
199.
WurfelMM, GordonAC, HoldenTD, RadellaF, StroutJ, KajikawaO, RuzinskiJT, RonaG, BlackRA, StrattonS, JarvikGP, HajjarAM, NickersonDA, RiederM, SevranskyJ, MaloneyJP, MossM, MartinG, ShanholtzC, GarciaJGN, GaoL, BrowerR, BarnesKC, WalleyKR, RussellJA, and MartinTR. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med, 178: 710–720, 2008.
200.
Wösten-van AsperenRM, LutterR, SpechtPA, MollGN, van WoenselJB, van der LoosCM, van GoorH, KamilicJ, FlorquinS, and BosAP. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1–7) or an angiotensin II receptor antagonist. J Pathol, 225: 618–627, 2011.
201.
YeSQ, SimonBA, MaloneyJP, Zambelli-WeinerA, GaoL, GrantA, EasleyRB, McVerryBJ, TuderRM, StandifordT, BrowerRG, BarnesKC, and GarciaJGN. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med, 171: 361–370, 2005.
202.
YeSQ, ZhangLQ, AdyshevD, UsatyukPV, GarciaAN, LavoieTL, VerinAD, NatarajanV, and GarciaJGN. Pre-B-cell-colony-enhancing factor is critically involved in thrombin-induced lung endothelial cell barrier dysregulation. Microvasc Res, 70: 142–151, 2005.
203.
YilinZ, YandongN, and FaguangJ. Role of angiotensin-converting enzyme (ACE) and ACE2 in a rat model of smoke inhalation induced acute respiratory distress syndrome. Burns, 41: 1468–1477, 2015.
204.
ZhangLQ, AdyshevDM, SingletonP, LiH, CepedaJ, HuangS-Y, ZouX, VerinAD, TuJ, GarciaJGN, and YeSQ. Interactions between PBEF and oxidative stress proteins-a potential new mechanism underlying PBEF in the pathogenesis of acute lung injury. FEBS Lett, 582: 1802–1808, 2008.
205.
ZhaoJ, YuH, LiuY, GibsonSA, YanZ, XuX, GaggarA, LiP-K, LiC, WeiS, BenvenisteEN, and QinH. Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol, 311: L868–L880, 2016.
206.
ZhouT, WangT, and GarciaJGN. A nonmuscle myosin light chain kinase-dependent gene signature in peripheral blood mononuclear cells is linked to human asthma severity and exacerbation status. Pulm Circ, 5: 335–338, 2015.
207.
ZhouT, WangT, and GarciaJGN. Genes influenced by the non-muscle isoform of myosin light chain kinase impact human cancer prognosis. PLoS One, 9: e94325, 2014.
208.
ZimlichmanE, HendersonD, TamirO, FranzC, SongP, YaminCK, KeohaneC, DenhamCR, and BatesDW. Health care-associated infections: a meta-analysis of costs and financial impact on the us health care system. JAMA Intern Med, 173: 2039–2046, 2013.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
